The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

Talk about a breath of fresh air. Researchers have developed a groundbreaking device that may one day make detecting lung cancer as easy as exhaling. “We built a screening tool that could allow ...

OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

Survival outcomes in non-small cell lung cancer: Real-world analysis of immunotherapy era vs pre-immunotherapy era, with insights into treatment settings, racial disparities, and socioeconomic impacts ...

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine ...